Xconomy: Adynxx News, Articles and Opinions

Entry	Author	Date	Location
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End	Ben Fidler	10/19/18	National
Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing	Frank Vinluan	10/12/18	San Francisco
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts	Ben Fidler	04/13/18	National
Despite Pain Drug’s Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test	Frank Vinluan	04/12/18	San Francisco
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More	Ben Fidler	01/13/17	National
Pain Drug Developer Adynxx Picks Up $16M for Another Clinical Trial	Frank Vinluan	01/10/17	San Francisco
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out	Ben Fidler	08/08/16	Boston
West Coast Biotech Roundup: Global Blood, Invitae, GeneWEAVE, Adynxx	Alex Lash	08/13/15	San Francisco
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout	Ben Fidler	02/04/15	Boston
East Coast Biotech Roundup: JP Morgan Edition	Ben Fidler	01/17/14	Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers	Luke Timmerman	03/25/13	National
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist	Bernadette Tansey	03/01/13	Boston
Cubist Pharmaceuticals Acquires Adynxx for Undisclosed Sum	VentureDeal	02/25/13	San Francisco
Adynxx Obtains $4,803,858 Series A Round	VentureDeal	12/27/10	San Francisco
Page 1 of 1